Senomyx Inc.  

(Public, NASDAQ:SNMX)   Watch this stock  
Find more results for Mary E. Herman
5.20
-0.16 (-2.99%)
Jul 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.13 - 5.54
52 week 4.16 - 10.11
Open 5.41
Vol / Avg. 209,716.00/221,723.00
Mkt cap 234.37M
P/E     -
Div/yield     -
EPS -0.34
Shares 43.73M
Beta 1.36
Inst. own 61%
Jul 29, 2015
Q2 2015 Senomyx Inc Earnings Release (Estimated) Add to calendar
May 29, 2015
Senomyx Inc Annual Shareholders Meeting (Estimated)
May 27, 2015
Senomyx Inc at Citi Global Consumer Conference
Apr 30, 2015
Q1 2015 Senomyx Inc Earnings Call - Webcast
Apr 30, 2015
Q1 2015 Senomyx Inc Earnings Release
Apr 14, 2015
Senomyx Inc at Needham Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -91.27% -43.92%
Operating margin -91.43% -44.06%
EBITD margin - -35.96%
Return on average assets -51.08% -30.46%
Return on average equity -81.57% -56.20%
Employees 110 -
CDP Score - -

Address

4767 Nexus Centre Drive
SAN DIEGO, CA 92121
United States - Map
+1-858-6468300 (Phone)
+1-858-4040752 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Senomyx, Inc. is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries to improve the nutritional profile of their products and generate cost of goods savings while maintaining or improving taste. The Company is engaged in the discovery, development and/or commercialization of flavor ingredients through five programs focused on sweet, savory, bitter, cooling and salt taste areas. It has developed taste receptor-based assays for use in its screening systems and to screen its compound libraries and identify potential flavor ingredients. It has identified S2383, a modifier of the sweetener sucralose; S6973 and S9632, two modifiers of sucrose, or common table sugar, and S617, a modifier of sucrose and high fructose corn syrup. It has also identified several sample classes of new cooling agents that demonstrate a taste proof-of-concept and display cooling properties.

Officers and directors

Kent Snyder Chairman of the Board
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John W. Poyhonen President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Antony E. Rogers Chief Financial Officer, Senior Vice President
Age: 48
Bio & Compensation  - Reuters
Donald S. Karanewsky Ph.D. Senior Vice President, Chief Scientific Officer
Age: 63
Bio & Compensation  - Reuters
Sharon Wicker Senior Vice President, Chief Commercial Development Officer
Age: 59
Bio & Compensation  - Reuters
Jay M. Short Ph.D. Lead Independent Director
Age: 56
Bio & Compensation  - Reuters
Roger D. Billingsley Ph.D. Independent Director
Age: 63
Bio & Compensation  - Reuters
Stephen A. Block Esq. Independent Director
Age: 70
Bio & Compensation  - Reuters
Mary Ann Gray Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters
Michael E. Herman Independent Director
Age: 73
Bio & Compensation  - Reuters